Navigation Links
AMICAS Announces Integrations at More Than 100 MEDITECH Facilities
Date:5/27/2008

Vision Series PACS milestone is a testament to tight integration and

excellent value

BOSTON, May 27 /PRNewswire-FirstCall/ -- AMICAS, Inc. (Nasdaq: AMCS), a leader in radiology and medical image and information management solutions, today announced that it has successfully integrated its Vision Series(TM) PACS at more than 100 facilities that use MEDITECH(TM) as their health information system. AMICAS will be showcasing Vision Series PACS at the 2008 International Medical Users Software Exchange (MUSE) Conference in Dallas, TX, from May 27 to 30. AMICAS will be in booth #530.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO )

"AMICAS has a proven track record of successfully implementing our PACS at more than 100 MEDITECH facilities across the country," said Paul Merrild, vice president of marketing at AMICAS. "Many facilities throughout the country have made an investment in MEDITECH -- and AMICAS allows them to fully leverage their investment when they choose our Vision Series PACS."

AMICAS is focused on developing solutions that allow facilities running a MEDITECH health information system to realize superior integration and value from their investment with MEDITECH. Complementing MEDITECH's core applications, the AMICAS product suite includes the following functionality:

-- Vision Series PACS offers the capability to securely launch an

encrypted image viewer that is embedded within numerous MEDITECH

products, including PCI and EMR. This allows users in other MEDITECH

applications to be "image-aware" without disrupting their daily

workflow, seamlessly launching the AMICAS products on an as-needed

basis.

-- Vision Watch(TM) offers reporting functionality that complements the

tools found in the MEDITECH RIS. These capabilities empower radiology

administrators with easily accessible information required to run their

departments and facilities effectively, such as data on referring

physician volume reports, imaging equipment utilization, and HIPAA

reporting needs -- all in a Web-based, drill-down, "point and click"

user interface.

-- Vision Series PACS includes a bi-directional interface with all

MEDITECH platforms. This interface returns relevant clinical data to

radiologists at their PACS workstations in order to enhance their

ability to diagnose their patients, thus increasing their efficiency

and that of the entire radiology department or facility.

"AMICAS' dedication to making MEDITECH customers successful extends beyond technical capabilities. We have invested, and will continue to invest, in products and services that complement those provided by MEDITECH. We focus on being collaborative and cooperative with MEDITECH for the benefit of our mutual customers. We believe this focus differentiates us from other PACS companies in the market," said Mr. Merrild.

AMICAS, Vision Series, and Vision Watch are trademarks or registered trademarks of AMICAS, Inc. All other company and trademark names are the property of their respective owners.

About AMICAS, Inc.

AMICAS, Inc. (http://www.amicas.com) is a leader in radiology and medical image and information management solutions. The AMICAS(R) Vision Series(TM) products provide a complete, end-to-end solution for imaging centers, ambulatory care facilities, and radiology practices. Acute care and hospital clients are provided a fully-integrated, HIS/RIS-independent PACS, featuring advanced enterprise workflow support and scalable design. Complementing the Vision Series product family is AMICAS Insight(TM) Solutions, a set of client- centered professional and consulting services that assist our customers with a well-planned transition to a digital enterprise.

CONTACT:

Aine Cryts

Marketing Communications Manager

617.779.7878

acryts@amicas.com


'/>"/>
SOURCE AMICAS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AMICAS Reports Financial Results for the First Quarter Ended March 31, 2008
2. AMICAS to Present at CIBC World Markets 18th Annual Healthcare Conference
3. CV Therapeutics Announces Presentations at the American Diabetes Association 68th Scientific Sessions
4. Epitomics Announces the Creation of 1000th Rabbit Monoclonal Antibody
5. NicOx Announces Departure of Damian Marron for CEO Position
6. CellCyte Genetics Corporation Announces Launch of Comprehensive Web site Powered by PRNewswire Investor Room Backend Technology
7. Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkins Lymphoma
8. Dragon Pharma Announces June 26, 2008 for 2008 Annual Shareholders Meeting
9. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
10. Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent
11. Amnis Announces Release of Its Extended Depth of Field Option for The ImageStream(R) System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... March 29, 2017 QIAGEN N.V. (NASDAQ: QGEN ... the U.S. launch of its ipsogen ® JAK2 RGQ PCR ... and Drug Administration as a qualitative in vitro diagnostic test for the detection ... ... processed on QIAGEN,s Rotor-Gene ® Q MDx system, which is a member ...
(Date:3/29/2017)... ... March 29, 2017 , ... (March 29, 2017) ... has been approved as an active member of the Mexican Direct Selling ... distributers and consumers in relationship marketing. This professional organization fosters loyal and fair ...
(Date:3/29/2017)... ... 29, 2017 , ... ACEA Biosciences, a privately owned biotechnology ... award to noteworthy scientists who will be presenting research using ACEA Biosciences’ technology ... awards are being given to two postdoctoral fellows studying pathogen capture by neutrophils, ...
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - The University ... partners Nordion, a business of Sterigenics International, and General ... has been submitted to the U.S. Nuclear Regulatory Commission ... U.S. production of molybdenum-99 (Mo-99). Once operational, production from ... of U.S. demand for Mo-99, which currently must be ...
Breaking Biology Technology:
(Date:2/14/2017)... 2017  Wake Forest Baptist Medical Center today announced Julie ... executive officer (CEO). Freischlag joins the medical center on ... , M.D., who last year announced that he would ... after leading it since 2008.   As ... Forest Baptist,s academic health system, which includes Wake Forest ...
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
(Date:2/9/2017)... , Feb. 9, 2017 The biomass boiler ... of the biomass boiler market globally in terms of ... biomass boilers. The market for biomass boilers has been ... end-user, application, and country/region. The market based on feedstock ... forest residues, biogas & energy crops, urban residues, and ...
Breaking Biology News(10 mins):